Login
Evidence Feed
About
Diagnostics
New
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
BIOMARKER:
BRCA2 mutation + CDK12 mutation
i
Other names:
CDK12, Cyclin Dependent Kinase 12, Cdc2-Related Kinase, Arginine/Serine-Rich, Cell Division Cycle 2-Related Protein Kinase 7, Cell Division Protein Kinase 12, CDC2-Related Protein Kinase 7, Cyclin-Dependent Kinase 12, CRKRS, CRK7, CDC2 Related Protein Kinase 7, HCDK12, CrkRS, CRKR, BRCA2, BRCC2, FACD, FAD, FAD1, FANCD, FANCD1, Breast cancer 2, early onset
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Entrez ID:
675
;
51755
Related biomarkers:
Expression
Mutation
CNA
Fusion
Others
‹
BRCA2 deletion (10)
BRCA2 exon 11 deletion (3)
BRCA2 amplification (2)
BRCA2 deletion + RB1 deletion (1)
CDK12 amplification (1)
CDK12 deletion (1)
HER-2 amplification + CDK12 amplification (0)
BRCA2 deletion (10)
BRCA2 exon 11 deletion (3)
BRCA2 amplification (2)
BRCA2 deletion + RB1 deletion (1)
CDK12 amplification (1)
CDK12 deletion (1)
HER-2 amplification + CDK12 amplification (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
BRCA2 mutation + CDK12 mutation
Prostate Cancer
BRCA2 mutation + CDK12 mutation
Prostate Cancer
GnRH stimulant
Resistant: C3 – Early Trials
GnRH stimulant
Resistant
:
C3
GnRH stimulant
Resistant: C3 – Early Trials
GnRH stimulant
Resistant
:
C3
^
^
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.
×
Unlock More with VERI
Sign up to access premium content
Email *
Password *
Confirm Password *
I'm not a robot
Please register with your email ID.